Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brakenhoff

Showing results (311-320 of 460) with videos related to

Pageof 46
Sort By:
BMC Cancer|August 7, 2019
Advancing interdisciplinary research in head and neck cancer through a multicenter longitudinal prospective cohort study: the NETherlands QUality of life and BIomedical Cohort (NET-QUBIC) data warehouse and biobankI M Verdonck-de Leeuw, F Jansen, R H Brakenhoff, et al.
British Journal of Cancer|March 7, 2007
Changes in the status of p53 affect drug sensitivity to thymidylate synthase (TS) inhibitors by altering TS levelsE Giovannetti, H H J Backus, D Wouters, et al.
BMC Cancer|October 24, 2019
Correction to: Advancing interdisciplinary research in head and neck cancer through a multicenter longitudinal prospective cohort study: the NETherlands QUality of life and BIomedical Cohort (NET-QUBIC) data warehouse and biobankI M Verdonck-de Leeuw, F Jansen, R H Brakenhoff, et al.
BMC Medical Research Methodology|January 23, 2022
Study retention and attrition in a longitudinal cohort study including patient-reported outcomes, fieldwork and biobank samples: results of the Netherlands quality of life and Biomedical cohort study (NET-QUBIC) among 739 head and neck cancer patients and 262 informal caregiversFemke Jansen, Ruud H Brakenhoff, Rob J Baatenburg de Jong, et al.
European Journal of Cancer (Oxford, England : 1990)|December 10, 2013
Cancer stem cell enrichment marker CD98: a prognostic factor for survival in patients with human papillomavirus-positive oropharyngeal cancerMichelle M Rietbergen, Sanne R Martens-de Kemp, Elisabeth Bloemena, et al.
The Journal of Pathology|July 29, 2025
New insights into the genetic progression of cancer through longitudinal analysis of oral lesionsLeon J Wils, Jos B Poell, Arjen Brink, et al.
European Journal of Cancer (Oxford, England : 1990)|February 7, 2016
Moving towards personalised therapy in head and neck squamous cell carcinoma through analysis of next generation sequencing dataM Giefing, M Wierzbicka, K Szyfter, et al.
Journal of Oral Pathology & Medicine : Official Publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology|September 25, 2023
The role of differentiated dysplasia in the prediction of malignant transformation of oral leukoplakiaLeon J Wils, Jos B Poell, Laura A N Peferoen, et al.
Genes, Chromosomes & Cancer|January 17, 2002
Discordance of genetic alterations between primary head and neck tumors and corresponding metastases associated with mutational status of the TP53 geneMaarten P Tabor, Viola M M van Houten, J Alain Kummer, et al.
Plos One|February 18, 2010
New class of monoclonal antibodies against severe influenza: prophylactic and therapeutic efficacy in ferretsRobert H E Friesen, Wouter Koudstaal, Martin H Koldijk, et al.
Pageof 46

Showing results (311-320 of 460) with videos related to

Sort By:
Pageof 46
BMC Cancer|August 7, 2019
Advancing interdisciplinary research in head and neck cancer through a multicenter longitudinal prospective cohort study: the NETherlands QUality of life and BIomedical Cohort (NET-QUBIC) data warehouse and biobankI M Verdonck-de Leeuw, F Jansen, R H Brakenhoff, et al.
British Journal of Cancer|March 7, 2007
Changes in the status of p53 affect drug sensitivity to thymidylate synthase (TS) inhibitors by altering TS levelsE Giovannetti, H H J Backus, D Wouters, et al.
BMC Cancer|October 24, 2019
Correction to: Advancing interdisciplinary research in head and neck cancer through a multicenter longitudinal prospective cohort study: the NETherlands QUality of life and BIomedical Cohort (NET-QUBIC) data warehouse and biobankI M Verdonck-de Leeuw, F Jansen, R H Brakenhoff, et al.
BMC Medical Research Methodology|January 23, 2022
Study retention and attrition in a longitudinal cohort study including patient-reported outcomes, fieldwork and biobank samples: results of the Netherlands quality of life and Biomedical cohort study (NET-QUBIC) among 739 head and neck cancer patients and 262 informal caregiversFemke Jansen, Ruud H Brakenhoff, Rob J Baatenburg de Jong, et al.
European Journal of Cancer (Oxford, England : 1990)|December 10, 2013
Cancer stem cell enrichment marker CD98: a prognostic factor for survival in patients with human papillomavirus-positive oropharyngeal cancerMichelle M Rietbergen, Sanne R Martens-de Kemp, Elisabeth Bloemena, et al.
The Journal of Pathology|July 29, 2025
New insights into the genetic progression of cancer through longitudinal analysis of oral lesionsLeon J Wils, Jos B Poell, Arjen Brink, et al.
European Journal of Cancer (Oxford, England : 1990)|February 7, 2016
Moving towards personalised therapy in head and neck squamous cell carcinoma through analysis of next generation sequencing dataM Giefing, M Wierzbicka, K Szyfter, et al.
Journal of Oral Pathology & Medicine : Official Publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology|September 25, 2023
The role of differentiated dysplasia in the prediction of malignant transformation of oral leukoplakiaLeon J Wils, Jos B Poell, Laura A N Peferoen, et al.
Genes, Chromosomes & Cancer|January 17, 2002
Discordance of genetic alterations between primary head and neck tumors and corresponding metastases associated with mutational status of the TP53 geneMaarten P Tabor, Viola M M van Houten, J Alain Kummer, et al.
Plos One|February 18, 2010
New class of monoclonal antibodies against severe influenza: prophylactic and therapeutic efficacy in ferretsRobert H E Friesen, Wouter Koudstaal, Martin H Koldijk, et al.
Pageof 46